Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
Clin Mol Hepatol 2023;29(2):433-452. Published online January 4, 2023
Background/Aims Global distribution of dominant liver cancer aetiologies has significantly changed over the past decades. This study analyzed the updated temporal trends of liver cancer aetiologies and sociodemographic status in 204 countries and territories from 1990 to 2019.
Methods The Global Burden of Disease 2019 report was used for statistical analysis. In addition, we performed stratification analysis to five quintiles using sociodemographic index and 21 geographic regions.
Results The crude numbers of liver cancer disease-adjusted life years (DALYs) and deaths significantly increased during the study period (DALYs; 11,278,630 in 1990 and 12,528,422 in 2019, deaths; 365,215 in 1990 and 484,577 in 2019). However, the Age-standardized DALY and mortality rates decreased. Hepatitis B virus (HBV) remains the leading cause of liver cancer DALYs and mortality, followed by hepatitis C virus (HCV), alcohol consumption, and non-alcoholic steatohepatitis/non-alcoholic fatty liver disease (NASH/NAFLD). Although Age-standardized DALY and mortality rates of liver cancer due to HBV and HCV have decreased, the rates due to alcohol consumption and NASH/NAFLD have increased. In 2019, the population of the East Asia region had the highest Age-standardized DALY and mortality rates, followed by high-income Asia-Pacific and Central Asia populations. Although East Asia and high-income Asia-Pacific regions showed a decrease during the study period, Age-standardized DALY rates increased in Central Asia. High-income North American and Australasian populations also showed a significant increase in Age-standardized DALY.
Conclusions Liver cancer remains an ongoing global threat. The burden of liver cancer associated with alcohol consumption and NASH/NAFLD is markedly increasing and projected to continuously increase.
Citations
Citations to this article as recorded by
Global, regional, and national burden of liver cancer due to hepatitis B, 1990–2021 and projections to 2051: a systematic analysis of the Global Burden of Disease Study 2021 Peipei Yang, Wenjie Huang, Yuanyuan Xu, Qiurong Li, Xinyan Shu, Jiaqian Zuo, Wenqin Ren, Yujie Huang, Yuhao Teng, Peng Shu European Journal of Gastroenterology & Hepatology.2026; 38(2): 178. CrossRef
Implementation of an alert system for the care cascade of Hepatitis C infection in patients undergoing elective surgery Jae Seung Lee, Ho Soo Chun, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Journal of Infection and Public Health.2026; 19(2): 103076. CrossRef
Epidemiological trends and age–period–cohort analysis of alcoholic liver cancer from 1990 to 2021 Jiajia Chen, Runhua Li, Xiaojie Li, Kai Shi, Rui Zeng, Kunpeng Hu, Qingliang Wang Hepatology International.2026; 20(2): 330. CrossRef
Decrypting potential mechanisms linking ochratoxin A to hepatocellular carcinoma: an integrated approach combining toxicology, machine learning, molecular docking, and molecular dynamics simulation Junyi Zhuo, Hua Wu, Xiaoling Zhou, Xi Wang, Tianqi Qiu, Min Lin, Yu Tang BMC Pharmacology and Toxicology.2026;[Epub] CrossRef
Differential expression and prognostic role of ACACA, ACLY, and FASN in schistosomiasis-associated versus hepatitis B virus-related liver cancer Xiao-Yi Wang, Yi-hui Sun, Qiong-Le Wu, Man-Man Liang, Zi-Jian Wang, Yao Hao, Zhi-Yu Pan, Xiu-Liang Xu, Jiang-Hua Yang Infectious Agents and Cancer.2026;[Epub] CrossRef
Global Burden of Gastrointestinal Cancers Among Adolescents and Young Adults Aged 15–39 Years and Lifestyle‐Associated Risk Factors Tingting Wei, Yunhai Li, Ze Zhang, Yijing Xu, Hongbo Huang, Ying Huang, Jiaying Li, Zheng Gong, Zhiqi Hu, Yichen Wang, Aijie Zhang, Fan Li Journal of Gastroenterology and Hepatology.2026; 41(3): 937. CrossRef
Differential Efficacy of Immunotherapy for Hepatocellular Carcinoma by Aetiology: A Systematic Review and Meta-Analysis Y. Li, X. Tan, S. Fang, C. So Clinical Oncology.2026; 52: 104075. CrossRef
Global Liver and Intrahepatic Bile Duct Cancer: A Comparative Study of the Survival Rate Hala H. Kareem, Humam Isam Abdulrahman European Journal of Medical and Health Research.2026; 4(2): 148. CrossRef
Sex-specific burdens of acute hepatitis B and C and their attributable risk factors in 204 countries and territories, 1990–2021 Zhonghua Sun, Yameng Xu, Jiansheng Xiao, Xiaozhu Liu, Yuwen Shangguan, Wencai Wang, Silei Chen, Wenhong Zhang Tropical Medicine and Health.2026;[Epub] CrossRef
Reproducibility and Sex Differences in a STZ–High-Fat Diet Model of MASLD and Early Hepatocarcinogenesis Marleigh Hefner, Raksa Andalib Hia, Tiffany Nguyen, Masoud Nateqi, Nikhil V. Dhurandhar, Vijay Hegde International Journal of Molecular Sciences.2026; 27(7): 3200. CrossRef
Joint Impact of Body Mass Index and High-Sensitivity C-Reactive Protein on Metabolic Dysfunction–Associated Steatotic Liver Disease Risk in Type 2 Diabetes Chenyang Jiao, Qian Xu, Xiangrong Li, Jun Weng, Kaiyue Lian, Hui Liu Metabolic Syndrome and Related Disorders.2026; 24(6): 267. CrossRef
Asian Burden of Liver Cancer 1990-2021 and Predictions to 2040: An Analysis of the Global Burden of Disease Study 2021 Liandong Chen, Weibo Zheng, Haojie Ying, Xinyue Chen, Han Yan, Binzhe Zhou, Yuyuan Sun, Qihui Shao, Hanyu Xu, Bowen Jin, Haonan Jin, Bin Fu Cancer Control.2026;[Epub] CrossRef
Global trends in metabolic-associated hepatocellular carcinoma: genetic and socio-demographic drivers Na Wu, Xinying Xiong, Xinyue Wang, Shuang Wei, Xinyu Shi, Yilin Chen, Wenjun Zhou, Jianying Wang, Lei Zhang, Baocheng Liu, Hualing Song, Huiting Yu, Guang Ji Hepatology International.2026;[Epub] CrossRef
Global burden of liver cancer mortality due to alcohol use from 1990 to 2021 and predictions to 2050 Jingyue Tan, Zixuan Xing, Jian Zu, Zhanpeng Yang, Yue Zhang, Xiao Yuan, Qiaoman Fei, Dou Qu, Chongyu Zhang, Yajing Bo, Zhiluo Yang, Xinyuan He, Meijuan Han, Fanpu Ji, Yujiao Deng, Yuan Wang Hepatoma Research.2026;[Epub] CrossRef
Factors associated with unmet psychological care needs and development of a Neuman systems model-based risk prediction model in patients with hepatocellular carcinoma Tong Wu, Qian Xu, Mugen Zhang Frontiers in Psychiatry.2026;[Epub] CrossRef
Impacts of hepatitis B and C prevention programmes on long-term outcomes of advanced liver disease and hepatocellular carcinoma: A systematic review Shenghan Cai, Putu Novi Arfirsta Dharmayani, Milena Lewandowska, Shalini Wijekulasuriya, Gifty Varghese, Ann Carrigan, Maryam Vizheh, Rose Boutros, Stephen Goodall, Jacob George, Amany Zekry, Yvonne Zurynski Public Health.2026; 258: 106384. CrossRef
Global, Regional, and National Burden of Liver Cancer from 1990 to 2021 and Projections to 2050: A Global Burden of Disease Study 2021 Dohwi Yun, Seohyun Hong, Kyeongeun Kim, Sooji Lee, Yesol Yim, Seoyoung Park, Yeona Jo, Seung Ha Hwang, Damiano Pizzol, Junyang Jung, Masoud Rahmati, Selin Woo, Dong Keon Yon Gut and Liver.2026; 20(4): 681. CrossRef
Disease burden and prediction of liver cancer attributable to metabolic risks in five East Asian countries from 1990 to 2023 Jialu Wang, Huijiao Wang, Zixuan Huang, Xiling Liu, Dehua Wang, Huimin Yan, Miquel Vall-llosera Camps PLOS One.2026; 21(8): e0342628. CrossRef
In vitro β-catenin attenuation by a mefloquine-loaded core–shell nano emulsion strategy to suppress liver cancer cells Priyadarshini Mohapatra, Natarajan Chandrasekaran Nanoscale Advances.2025; 7(3): 748. CrossRef
Epidemiological trends in gastrointestinal cancers and risk factors across U.S. states from 2000 to 2021: a systematic analysis for the global burden of disease study 2021 Jiahao Jiang, Zhiqin Xie, Qingbin Wang, Bingkun Wang, Rong Huang, Weikai Xu, Changzhen Shang, Yajin Chen BMC Public Health.2025;[Epub] CrossRef
Regional Variations in the Prevalence of Risk Factors and Non-Communicable Diseases in Papua New Guinea: A Scoping Review Bobby Porykali, Ryley Gronau, Phyllis Tran, Juliana Chen, Margaret Allman-Farinelli, Anna Rangan, Shelina Porykali, Robin Oge, Hans Nogua, Alyse Davies International Journal of Environmental Research and Public Health.2025; 22(1): 102. CrossRef
Burden, trends, and predictions of liver cancer in China, Japan, and South Korea: analysis based on the Global Burden of Disease Study 2021 Si Yang, Yujiao Deng, Yi Zheng, Jing Zhang, Dongdong He, Zhijun Dai, Changcun Guo Hepatology International.2025; 19(2): 441. CrossRef
Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study Edison Xu, Parissa Tabrizian, Julio Gutierrez, Maarouf Hoteit, Tara Ghaziani, Kali Zhou, Neehar Parikh, Veeral Ajmera, Elizabeth Aby, Amy Shui, Rebecca Marino, Allison Martin, Christopher Wong, Karissa Kao, Shravan Dave, Sander Florman, Francis Yao, Neil Hepatology.2025; 82(3): 612. CrossRef
Global, regional and country burden of high BMI-related liver cancer among individuals aged above 70: trends from 1990 to 2021 and projections to 2044 Ke-Jie He, Wanyi Shu, Yanggang Hong Frontiers in Public Health.2025;[Epub] CrossRef
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment Soo Young Hwang, Pojsakorn Danpanichkul, Vatche Agopian, Neil Mehta, Neehar D. Parikh, Ghassan K. Abou-Alfa, Amit G. Singal, Ju Dong Yang Clinical and Molecular Hepatology.2025; 31(Suppl): S228. CrossRef
Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma Bingyan Hao, Yachong Liu, Bohan Wang, Haofeng Wu, Yan Chen, Lei Zhang Experimental Hematology & Oncology.2025;[Epub] CrossRef
Systems pharmacology of phytochemical anacardic acid in the chemoprevention of hepatocellular carcinoma Sangita Panda, Enketeswara Subudhi, Sweta Padma Routray, Sujit Nair Drug Metabolism and Personalized Therapy.2025; 40(2): 107. CrossRef
Mediational role of metabolic syndrome between physical activity, sedentary behavior and non-alcoholic fatty liver disease: a cross-sectional study Zhaoyu Ren, Hongxuan Fan, Yaya Xue, Xinyu Yang, Xuchang Liu, Jing Luo, Jianqi Zhao, Leigang Wang, Yao Zhang, Bin Liang BMC Public Health.2025;[Epub] CrossRef
Effectiveness of herbal medicine for liver cancer treatment as revealed by a bibliometric and visualization analysis Yusha Shi, Juwei Wang, Yahui Zhang, Kai Wu, Yibo Zhu, Kaiwen Yan, Qin Ouyang Frontiers in Oncology.2025;[Epub] CrossRef
The spatio-temporal trends and determinants of liver cancer attributable to specific etiologies: a systematic analysis from the Global Burden of Disease Study 2021 Jinli Liu, Tingling Xu, Yanan Wang, Fanpu Ji, Lei Zhang Global Health Research and Policy.2025;[Epub] CrossRef
Targeting super-enhancers in liver cancer: from pathogenic mechanisms to clinical applications Chang-Lei Li, Zhi-Yuan Yao, Ao Sun, Jing-Yu Cao, Zu-Sen Wang Frontiers in Pharmacology.2025;[Epub] CrossRef
The CRP–albumin–lymphocyte index provides enhanced prognostic value in liver cancer compared to the TNM staging system Hong Zhao, Bing Yin, Xiang-Rui Li, Xiao-Yue Liu, Zhao-Ting Bu, Han-Ping Shi Scientific Reports.2025;[Epub] CrossRef
Dynamic changes of serum cytokines and their prognostic values in patients with hepatocellular carcinoma treated by thermal ablation Kelvin K. C. Ng, Charing C. N. Chong, Chun‐Kwok Wong, Nathalie Wong Surgical Practice.2025; 29(3): 154. CrossRef
Liver‐specific lncRNAs associated with liver cancers Olga Y. Burenina, Roman K. Makarchenko, Maria P. Rubtsova, Olga A. Dontsova FEBS Open Bio.2025; 15(9): 1383. CrossRef
Global trends and heterogeneity in the burden of brain and central nervous system cancers among children and adolescents: An analysis based on GBD 2021 data Libo Xu, Zhenhao Wang, Qingsong Li Journal of Clinical Neuroscience.2025; 139: 111452. CrossRef
Epidemiological Trends and Projection of Liver Cancer Due to Nonalcoholic Steatohepatitis Among People Aged 55 Years and Older in China From 1990 to 2030: An Analysis of the Global Burden of Disease Study 2021 Xi Yang, Xiaodan Yin, Huiqi Wu, Qiaomei Li, Yang Shen Clinical and Translational Gastroenterology.2025; 16(8): e00872. CrossRef
Epidemiology of liver cancer in Kazakhstan: data from the Unified National Electronic Health System, 2014–2023 Ayana Ablayeva, Dmitriy Syssoyev, Ruslan Akhmedullin, Altynay Beyembetova, Diyora Abdukhakimova, Temirgali Aimyshev, Iliyar Arupzhanov, Gulnur Zhakhina, Aigerim Biniyazova, Temirlan Seyil, Nurbek Igissin, Yuliya Semenova, Abduzhappar Gaipov, Ali Faramarzi PLOS One.2025; 20(8): e0330423. CrossRef
Exploration of the Mechanism of Action of Dendrobium officinale in the Treatment of Liver Cancer Based on Network Pharmacology, Molecular Docking and in vitro Validation Shuimeng Zhan, Xinyan Lu, Hongyan Guo, Yang Liu, Zhi Li, Wei Xu, Fang Xia, Huanjun Tang, Yi Tian, Jing Chen, Xuan Lin Journal of Hepatocellular Carcinoma.2025; Volume 12: 1973. CrossRef
Translational Potential of Surface Engineered Extracellular Vesicles as Theranostic Nanocarriers in Cancer Management: Recent Developments from Bench to Bedside Ravindra Vasave, Rohit Bhawale, Omar Khan, Ekta Pardhi, Naveen Rajana, Nalla Usha Kumari, Padakanti Sandeep Chary, Neelesh Kumar Mehra ACS Applied Bio Materials.2025; 8(8): 6647. CrossRef
Novel Therapeutics for Hepatocellular Carcinoma Mohamed I. Elsaid, Ashish Manne Clinics in Liver Disease.2025; 29(4): 673. CrossRef
The global epidemiology of gastrointestinal cancers attributable to high-BMI: findings from the Global Burden of Disease Study 2021 Laiang Yao, Tao Ji, Hailian Mu, Xiangming Xu Frontiers in Nutrition.2025;[Epub] CrossRef
Prospects of late-stage development agents in the treatment of metabolic dysfunction-associated steatohepatitis Brian Lee, Ussama Ghumman, Lisa D. Pedicone, Andres Gomez Aldana, Eric Lawitz Clinical and Molecular Hepatology.2025; 31(4): 1167. CrossRef
The economic ramifications of liver cancer on a global, regional, and national scale Jie Yu, Qiaoyi Chen, Jin Ma Frontiers in Medicine.2025;[Epub] CrossRef
Ficus pandurata as a Functional Phytotherapeutic: Inhibiting JAK2/STAT3 Signaling and Activating Mitochondrial Apoptosis in Hepatocellular Carcinoma Muhammad Majid, Bing Tang, Yingyao Lai, Xiaoyan Pang, Yongdui Ruan, Hui Shi, Weiwen Peng, Weibo Dai, Xianjing Hu Food Science & Nutrition.2025;[Epub] CrossRef
Mangiferin: a novel hepatoprotective for liver cirrhosis via modulation of histological, cellular, biochemical, inflammatory markers and oxidative stress Khaled Abdul-Aziz Ahmed, Suhayla Hamad Shareef, Haween Toufiq Nanakaly, Mohammed A. Ali, Derin Nabaz Fisal, Peshawa Yunis Aziz, Nabaz Fisal Shakir Agha, Mahmood Ameen Abdulla, Ahmed A. Salman BMC Pharmacology and Toxicology.2025;[Epub] CrossRef
Emerging DNA- and RNA-based therapeutic strategies in hepatocellular carcinoma: A molecular approach to precision medicine Zulfa Nooreen, Ankita Wal, Anjali Shukla, A. Venkata Badarinath, Nishant Kumar, Tanmay Sarma, Abida Khan, Amin Gasmi Letters in Drug Design & Discovery.2025; 22(11): 100268. CrossRef
The Epidemiology of Hepatitis B Virus Infection in Korea: 15-Year Analysis Log Young Kim, Jeong-Ju Yoo, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Dong Hyeon Lee, Jae Young Jang Journal of Korean Medical Science.2024;[Epub] CrossRef
Investigating Alternative Treatment Options Unfeasible for Local Ablation Therapy in Patients with Small Solitary Hepatocellular Carcinomas Chang Hun Lee, In Hee Kim Gut and Liver.2024; 18(1): 5. CrossRef
Hepatitis B Virus Elimination Strategies Mimi Xu, Norah A. Terrault Current Hepatology Reports.2024; 23(2): 268. CrossRef
Role of Imaging in Screening for Hepatocellular Carcinoma Irfan A. Kazi, Vinay Jahagirdar, Bareen W. Kabir, Almaan K. Syed, Asad W. Kabir, Abhilash Perisetti Cancers.2024; 16(19): 3400. CrossRef
The HHEX-ABI2/SLC17A9 axis induces cancer stem cell-like properties and tumorigenesis in HCC Huizi Li, Jin Liu, Jie Lai, Xinyao Su, Xiaofeng Wang, Jiaqing Cao, Shengxun Mao, Tong Zhang, Qiuping Gu Journal of Translational Medicine.2024;[Epub] CrossRef
Impact of drug dispersion on tumor-effector dynamics during combined chemo-immunotherapy with sensitivity analysis Lazaro Revocatus Mashiku, Joseph Protas Ndenda, Reuben Maghembe, Sachin Shaw Applied Mathematical Modelling.2024; 134: 148. CrossRef
Inflammation as a pathway for heavy metal-induced liver damage—Insights from a repeated-measures study in residents exposed to metals and bioinformatics analysis Shuanzheng Zhao, Guohuan Yin, Meiduo Zhao, Jingtao Wu, Xiaolin Liu, Lanping Wei, Qun Xu, Jing Xu International Journal of Hygiene and Environmental Health.2024; 261: 114417. CrossRef
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients Maria Eva Argenziano, Mi Na Kim, Michele Montori, Alessandro Di Bucchianico, Daniele Balducci, Sang Hoon Ahn, Gianluca Svegliati Baroni Hepatology International.2024; 18(S2): 922. CrossRef
An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences Roaa Khalil, Kholoud Al-Mahzoum, Muna Barakat, Malik Sallam Pathogens.2024; 13(8): 674. CrossRef
Burden of alcohol use disorder and its consequences in Iran from 1990 to 2019: Findings from the global burden of disease study Khashayar Danandeh, Pegah Rasoulian, Homa Seyedmirzaei, Behnaz Mahmoudvand, Behnood Avand Amini, Fatemeh Samadian, Golnaz Ranjbar Pazuki, Amir Hossein Memari, Amin Nakhostin-Ansari Preventive Medicine Reports.2024; 46: 102872. CrossRef
Correlation with Apoptosis Process through RNA-Seq Data Analysis of Hep3B Hepatocellular Carcinoma Cells Treated with Glehnia littoralis Extract (GLE) Min-Yeong Park, Sujin Lee, Hun-Hwan Kim, Se-Hyo Jeong, Abuyaseer Abusaliya, Pritam Bhangwan Bhosale, Je-Kyung Seong, Kwang-Il Park, Jeong-Doo Heo, Meejung Ahn, Hyun-Wook Kim, Gon-Sup Kim International Journal of Molecular Sciences.2024; 25(17): 9462. CrossRef
Global epidemiology of liver cancer 2022: An emphasis on geographic disparities Qianru Li, Chao Ding, Maomao Cao, Fan Yang, Xinxin Yan, Siyi He, Mengdi Cao, Shaoli Zhang, Yi Teng, Nuopei Tan, Jiachen Wang, Changfa Xia, Wanqing Chen Chinese Medical Journal.2024; 137(19): 2334. CrossRef
Liver Cancer and Risk Factors in the MENA Region: Epidemiology and Temporal Trends Based on the 2019 Global Burden of Disease Data Najla A. Lakkis, Nour M. Mokalled, Mona H. Osman, Umayya M. Musharrafieh, Mohammad Eljammal Cancer Control.2024;[Epub] CrossRef
Liver Cancer Etiology: Old Issues and New Perspectives Jian-Guo Chen, Yong-Hui Zhang, Jian-Hua Lu, Thomas W. Kensler Current Oncology Reports.2024; 26(11): 1452. CrossRef
Neighborhood opportunity is associated with completion of hepatocellular carcinoma surveillance prior to the diagnosis of hepatocellular carcinoma in patients with cirrhosis Joanna Jiang, Erin Bouquet, Yesung Kweon, Mohamed I. Elsaid, Dayssy A. Diaz, Lanla Conteh, Lindsay A. Sobotka Clinics and Research in Hepatology and Gastroenterology.2024; 48(10): 102485. CrossRef
Incorporating ALBI Grade with Geriatric Nutritional Risk Index Enhances Hepatocellular Carcinoma Risk Stratification Heechul Nam, Pil Soo Sung, Sung Won Lee, Do Seon Song, Jung Hyun Kwon, Jeong Won Jang, Chang Wook Kim, Si Hyun Bae Liver Cancer.2024; : 1. CrossRef
The Evolving Landscape of Hepatocellular Carcinoma Mortality in the US Emad Qayed JAMA Network Open.2024; 7(11): e2445533. CrossRef
Phytochemical Profiling, Acute Toxicity, and Hepatoprotective Effects of Anchusa Limbata in Thioacetamide‐Induced Liver Cirrhosis in Rats Khaled Abdul‐Aziz Ahmed, Ahmed A. J. Jabbar, Mohammed M. Hussein M. Raouf, Ayman M. Al‐Qaaneh, Rawaz Rizgar Hassan, Musher Ismael Salih, Ramzi A. Mothana, Gadah Abdulaziz Al‐Hamoud, Mahmood Ameen Abdulla, Sidgi Hasson, Parween Abdul‐samad Ismail Food Science & Nutrition.2024; 12(12): 10628. CrossRef
Withdrawn: Acute Rejection was Observed in a Combination Therapy of CTLA-4 and PD-1 Inhibitors Before Liver Transplantation: A Case Report and Literature Review Pengpeng Zhang, Tianyin Wang, Hong Liu, Xingguo She, Ke Chen, Yujun Zhao, Yingzi Ming iLIVER.2023;[Epub] CrossRef
The latest global burden of liver cancer: A past and present threat Joo Hyun Oh, Dae Won Jun Clinical and Molecular Hepatology.2023; 29(2): 355. CrossRef
The current trends in the health burden of primary liver cancer across the globe Peter Konyn, Aijaz Ahmed, Donghee Kim Clinical and Molecular Hepatology.2023; 29(2): 358. CrossRef
Global trajectories of liver cancer burden from 1990 to 2019 and projection to 2035 Fan Yang, Dianqin Sun, Changfa Xia, He Li, Maomao Cao, Xinxin Yan, Siyi He, Shaoli Zhang, Wanqing Chen Chinese Medical Journal.2023; 136(12): 1413. CrossRef
Evaluation of the Safety and Efficacy of Conventional Transarterial Chemoembolization (cTACE) and Drug-Eluting Bead (DEB)-TACE in the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review Javaria Ayyub, Karan Nareshbhai Dabhi, Namra V Gohil, Nida Tanveer, Sally Hussein, Shravya Pingili, Vijaya Krishna Makkena, Arturo P Jaramillo, Babatope L Awosusi, Tuheen Sankar Nath Cureus.2023;[Epub] CrossRef
Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study Chang Hun Lee, Gwang Hyeon Choi, Hwa Young Choi, Sojung Han, Eun Sun Jang, Young Eun Chon, Young Chang, Kyung-Ah Kim, Do Young Kim, Hyung Joon Yim, Hye-Lin Kim, Sook-Hyang Jeong, In Hee Kim Clinical and Molecular Hepatology.2023; 29(3): 779. CrossRef
Risk factors associated with late hepatocellular carcinoma detection in patients undergoing regular surveillance Sangmi Jang, Young-Joo Jin, Jin-Woo Lee, Dam Kwon, Jung Hwan Yu Medicine.2023; 102(32): e34637. CrossRef
Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990–2019: a decomposition and age–period–cohort analysis Chunlong Liu, Shijie Zhu, Jian Zhang, Panpan Wu, Xuan Wang, Sen Du, Enzhao Wang, Yunkang Kang, Kun Song, Jiangtao Yu Journal of Gastroenterology.2023; 58(12): 1222. CrossRef
Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Satoru Saito, Atsushi Nakajima Gut and Liver.2023; 17(6): 843. CrossRef
Potential Anti-Cancer Effects of Extra Virgin Olive Oil and Its Phenolic Extracts on Hepatocellular Carcinoma Cells Gül KAHRAMAN, Mücahit Taha ÖZKAYA, Özlem YILDIRIM International Journal of Nature and Life Sciences.2023; 7(2): 112. CrossRef
Current epidemiology of chronic liver disease Richie Manikat, Aijaz Ahmed, Donghee Kim Gastroenterology Report.2023;[Epub] CrossRef
First
Prev
